BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28849027)

  • 21. [Protein microarray analysis on changes in protein phosphorylation in recurrent nasopharyngeal carcinoma].
    Su HF; Zhang XB; Fang M; He QC; Li WF; Wu SX
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(45):3219-22. PubMed ID: 22333108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma.
    Tulalamba W; Larbcharoensub N; Sirachainan E; Tantiwetrueangdet A; Janvilisri T
    Tumour Biol; 2015 Aug; 36(8):5931-42. PubMed ID: 25724187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low expression of succinate dehydrogenase subunit B in locally recurrent nasopharyngeal carcinoma and implication for prognosis].
    Lin S; Dai Z; Chen C; Pan S; Liao Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):38-42. PubMed ID: 25764926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of five secretory proteins with the nasopharyngeal carcinoma metastasis and the clinical applications.
    Tao Y; Wang K; Chen Z; Long L; Wu Q; Cui F; Zhu L; Xiang M; Jiang Y; Liang Y; Qiu S; Xiao Z; Yi B
    Oncotarget; 2017 Apr; 8(17):29383-29394. PubMed ID: 28107202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
    BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
    Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
    Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
    Ye M; Huang T; Ni C; Yang P; Chen S
    EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased production of nitric oxide correlates with tumor growth in Algerian patients with nasopharyngeal carcinoma.
    Bourouba M; Boukercha A; Zergoun AA; Zebboudj A; Elhadjan M; Djenaoui D; Asselah F; Touil-Boukoffa C
    Biomarkers; 2012 Nov; 17(7):618-24. PubMed ID: 22817561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma.
    Zhao Y; Shen L; Huang X; Jing D; Huang D; Fu J; Li Z; Zhang G; Shen L
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):390-396. PubMed ID: 28947213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.
    Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary report on the role of endoscopic endonasal nasopharyngectomy in recurrent rT3 and rT4 nasopharyngeal carcinoma.
    Wong EHC; Liew YT; Abu Bakar MZ; Lim EYL; Prepageran N
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):275-281. PubMed ID: 27520568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
    Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL
    BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
    Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
    J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Zhu XD; Su F; Liang ZG; Li L; Qu S; Liang X; Wang Q; Liang SX; Chen L
    Int J Clin Oncol; 2014 Aug; 19(4):579-85. PubMed ID: 24072388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
    Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
    Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing.
    Peng WS; Zhou X; Yan WB; Li YJ; Du CR; Wang XS; Shen CY; Wang QF; Ying HM; Lu XG; Xu TT; Hu CS
    Oncoimmunology; 2022; 11(1):2026583. PubMed ID: 35096485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation.
    Wu CC; Peng PH; Chang YT; Huang YS; Chang KP; Hao SP; Tsang NM; Yeh CT; Chang YS; Yu JS
    Proteomics; 2008 Sep; 8(17):3605-20. PubMed ID: 18668694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system.
    You R; Zou X; Wang SL; Jiang R; Tang LQ; Zhang WD; Li L; Zhang MX; Shen GP; Guo L; Qian CN; Mai HQ; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Sep; 51(13):1771-9. PubMed ID: 26055204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
    Feng X; Zhang J; Chen WN; Ching CB
    J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrow-band imaging for detecting early recurrent nasopharyngeal carcinoma.
    Lin YC; Wang WH
    Head Neck; 2011 Apr; 33(4):591-4. PubMed ID: 20029983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.